U.K. Biotechnology & Pharmaceutical Services Outsourcing Market Development Trends of Analysis Report by 2028
U.K. Biotechnology & Pharmaceutical Services Outsourcing Industry Overview The U.K. biotechnology and pharmaceutical services outsourcing market was estimated at USD 2.3 billion in 2020 and is projected to expand at a compound annual growth rate (CAGR) of 6.9% from 2021 to 2028. This is due to growing drug development costs coupled with high clinical development failure rates and increasing outsourcing of R&D activities. Patents of many drugs are expected to expire in the near future, which is anticipated to drive the biosimilars market. This, in turn, is anticipated to boost R&D activities of companies for commercializing a generic version of drugs. The launch of generics in the market in a feasible timeline and cost is anticipated to drive the demand for CROs. Gather more insights about the market drivers, restrains and growth of the U.K. Biotechnology & Pharmaceutical Services Outsourcing Market Outsourcing has evolved into a multibillion-dollar industry. The ...